1,720,973 research outputs found
Tedizolid (TR-701): A new oxazolidinone with enhanced potency
Introduction: Tedizolid phosphate (TR-701) is a new oxazolidinone prodrug that is transformed in the serum into the active drug tedizolid (TR-700). Tedizolid acts by inhibiting protein synthesis and has broad activity against Gram-positive pathogens, including strains that are resistant to linezolid. Areas covered: This review summarizes the currently available data on this new antimicrobial agent. In vitro activity, pharmacokinetics-pharmacodynamics, clinical efficacy and safety are all addressed. Expert opinion: Tedizolid will provide a useful addition to the antimicrobial armamentarium, particularly in complicated skin and skin structure infections, due to its high oral bioavailability and once-daily dosing. The results of future studies will serve to better position tedizolid among the newly approved agents for infections caused by Gram-positive organisms. © 2012 Informa UK, Ltd.[Anonymous], 2001, AM J INFECT CONTROL, V29, P404; Betriu C, 2010, ANTIMICROB AGENTS CH, V54, P2212, DOI 10.1128-AAC.01653-09; Bien P., 2010, 50 INT C ANT AG CHEM; Brown SD, 2010, ANTIMICROB AGENTS CH, V54, P2063, DOI 10.1128-AAC.01569-09; Chang S, 2003, NEW ENGL J MED, V348, P1342, DOI 10.1056-NEJMoa025025; Colak D, 2002, J ANTIMICROB CHEMOTH, V50, P397, DOI 10.1093-jac-dkf134; Colca JR, 2003, J BIOL CHEM, V278, P21972, DOI 10.1074-jbc.M302109200; Dreskin H, 2011, 51 INT C ANT AG CHEM; Falagas ME, 2006, J ANTIMICROB CHEMOTH, V58, P273, DOI 10.1093-jac-dkl219; Fluit AC, 2001, J CLIN MICROBIOL, V39, P3727, DOI 10.1128-JCM.39.10.3727-3732.2001; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056-NEJMoa043252; Gould IM, 2008, INT J ANTIMICROB AG, V31, P1, DOI 10.1016-S0924-8579(08)70002-5; Hiramatsu K, 1997, J ANTIMICROB CHEMOTH, V40, P135, DOI 10.1093-jac-40.1.135; Housman ST, 2011, 51 INT C ANT AG CHEM; Hsueh PR, 1999, INFECT CONT HOSP EP, V20, P828, DOI 10.1086-501592; Im WB, 2011, EUR J MED CHEM, V46, P1027, DOI 10.1016-j.ejmech.2011.01.014; Jacobson LM, 2009, PEDIATR INFECT DIS J, V28, P445, DOI 10.1097-INF.0b013e3181927891; Jones RN, 2009, J ANTIMICROB CHEMOTH, V63, P716, DOI 10.1093-jac-dkp021; Keel RA, 2011, 51 INT C ANT AG CHEM; Kirst HA, 1998, ANTIMICROB AGENTS CH, V42, P1303; Leach KL, 2007, MOL CELL, V26, P393, DOI 10.1016-j.molcel.2007.04.005; LECLERCQ R, 1988, NEW ENGL J MED, V319, P157, DOI 10.1056-NEJM198807213190307; Lemaire S, 2009, J ANTIMICROB CHEMOTH, V64, P1035, DOI 10.1093-jac-dkp267; Livermore DM, 2009, J ANTIMICROB CHEMOTH, V63, P713, DOI 10.1093-jac-dkp002; Locke JB, 2009, ANTIMICROB AGENTS CH, V53, P5265, DOI 10.1128-AAC.00871-09; Louie A, 2011, ANTIMICROB AGENTS CH, V55, P3453, DOI 10.1128-AAC.01565-10; Mangili A, 2005, CLIN INFECT DIS, V40, P1058, DOI 10.1086-428616; Moellering RC, 2003, ANN INTERN MED, V138, P135; Moise PA, 2000, INT J ANTIMICROB AG, V16, pS31; Munoz KA, 2011, 21 EUR C CLIN MICR I; Prasad JV, 2007, CURR OPIN MICROBIOL, V10, P454, DOI 10.1016-j.mib.2007.08.001; Prokocimer P, 2008, 48 INT C ANT AG CHEM; Prokocimer P, 2011, ANTIMICROB AGENTS CH, V55, P583, DOI 10.1128-AAC.00076-10; Ramsey AM, 2009, INFECT CONT HOSP EP, V30, P184, DOI 10.1086-593956; Rodriguez-Avial I, 2012, J ANTIMICROB CHEMOTH, V67, P167, DOI 10.1093-jac-dkr403; Sakoulas G, 2004, J CLIN MICROBIOL, V42, P2398, DOI 10.1128-JCM.42.6.2398-2402.2004; Garcia MS, 2010, JAMA-J AM MED ASSOC, V303, P2260, DOI 10.1001-jama.2010.757; Schaadt R, 2009, ANTIMICROB AGENTS CH, V53, P3236, DOI 10.1128-AAC.00228-09; Shaw KJ, 2008, ANTIMICROB AGENTS CH, V52, P4442, DOI 10.1128-AAC.00859-08; SMALL PM, 1990, ANTIMICROB AGENTS CH, V34, P1227; UTTLEY AHC, 1989, EPIDEMIOL INFECT, V103, P173; van Hal SJ, 2011, EUR J CLIN MICROBIOL, V30, P603, DOI 10.1007-s10096-010-1128-3; VOSS A, 1994, EUR J CLIN MICROBIOL, V13, P50, DOI 10.1007-BF02026127; Woods CW, 2004, CLIN INFECT DIS, V38, P1188, DOI 10.1086-383027; Yamaki J, 2011, ANTIMICROB AGENTS CH, V55, P4432, DOI 10.1128-AAC.00122-11; Yum JH, 2010, ANTIMICROB AGENTS CH, V54, P5381, DOI 10.1128-AAC.00728-10; Zetola N, 2005, LANCET INFECT DIS, V5, P275, DOI 10.1016-S1473-3099(05)70112-214171
Going Beyond Counting First Authors in Author Co-citation Analysis
The present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
Variations on the Author
“Variations on the Author” discusses two of Eduardo Coutinho’s recent films (Um Dia na Vida, from 2010, and Últimas Conversas, posthumously released in 2015) and their contribution to the general question of documentary authorship. The director’s filmography is characterized by a consistent yet self-effacing form of authorial self-inscription: Coutinho often features as an interviewer that rather than express opinions propels discourses; an interviewer that is good at listening. This mode of self-inscription characterizes him as an author who is not expressive but who is nonetheless markedly present on the screen. In Um Dia na Vida, however, Coutinho is completely absent form the image, while Últimas Conversas, on the contrary, includes a confessional prologue that moves the director from the margins to the center of his films. This article examines the ways in which these works stand out in the filmography of a director who offers new insights into the notion of cinematic authorship
Appropriate Similarity Measures for Author Cocitation Analysis
We provide a number of new insights into the methodological discussion about author cocitation analysis. We first argue that the use of the Pearson correlation for measuring the similarity between authors’ cocitation profiles is not very satisfactory. We then discuss what kind of similarity measures may be used as an alternative to the Pearson correlation. We consider three similarity measures in particular. One is the well-known cosine. The other two similarity measures have not been used before in the bibliometric literature. Finally, we show by means of an example that our findings have a high practical relevance.information science;Pearson correlation;cosine;similarity measure;author cocitation analysis
Dispelling the Myths Behind First-author Citation Counts
We conducted a full-scale evaluative citation analysis study of scholars in the XML research field to explore just how different from each other author rankings resulting from different citation counting methods actually are, and to demonstrate the capability of emerging data and tools on the Web in supporting more realistic citation counting methods. Our results contest some common arguments for the continued
use of first-author citation counts in the evaluation of scholars, such as high correlations between author rankings by first-author citation counts and other citation
counting methods, and high costs of using more realistic citation counting methods that are not well-supported by the ISI databases. It is argued that increasingly available digital full text research papers make it possible for citation analysis studies to go beyond what the ISI databases have directly supported and to employ more
sophisticated methods
koamabayili/VECTRON-author-checklist: VECTRON author checklist
We have done our best to complete the author checklist relating to the use of animals in the hut study. Note that the objective for the hut study was to evaluate the IRS treatment applications for residual efficacy against Anopheles mosquitoes, including the local An. coluzzii mosquito population. Cows were only used to attract mosquitoes into the huts and no tests were carried out directly on the cows. The author checklist is intended for use with studies where experiments are carried out on animals, which is why we have had such difficulty in completing this for the hut study, as many of the questions do not relate to how the cows were used
Author-wise bibliometric analysis based on entropy.
Author-wise bibliometric analysis based on entropy.</p
Author Under Sail The Imagination of Jack London, 1893-1902
In Author Under Sail, Jay Williams offers the first complete literary biography of Jack London as a professional writer engaged in the labor of writing. It examines the authorial imagination in London's work, the use of imagination in both his fiction and nonfiction, and the ways he defined imagination in the creative process in his business dealings with his publishers, editors, and agents. In this first volume of a two-volume biography, Williams traverses the years 1893 to 1902, from London's "Story of a Typhoon" to The People of the Abyss. The Jack London who emerges in the pages of Author Under Sail is a writer whose partnership with publishers, most notably his productive alliance with George Brett of Macmillan, was one of the most formative in American literary history. London pioneered many author models during the heyday of realism and naturalism, blurring the boundaries of these popular genres by focusing on absorption and theatricality and the representation of the seen and unseen. London created an impassioned, sincere, and extremely personal realism unlike that of other American writers of the time. Author Under Sail is a literary tour de force that reveals the full range of London as writer, creative citizen, and entrepreneur at the same time it sheds light on the maverick side of machine-age literature.Intro -- Title Page -- Copyright Page -- Dedication -- Contents -- Acknowledgments -- Introduction -- 1. Spirit Truth -- 2. From Absorption to Theatricality and Back Again -- 3. "I Will Build a New Present" -- 4. Sons as Authors -- 5. Fathers as Publishers -- 6. The Daughter as Author -- 7. Lovers as Authors -- 8. At Sea with the Family -- 9. Yellow News, Yellow Stories -- 10. The Return Home -- Notes -- Bibliography -- Index -- About Jay WilliamsIn Author Under Sail, Jay Williams offers the first complete literary biography of Jack London as a professional writer engaged in the labor of writing. It examines the authorial imagination in London's work, the use of imagination in both his fiction and nonfiction, and the ways he defined imagination in the creative process in his business dealings with his publishers, editors, and agents. In this first volume of a two-volume biography, Williams traverses the years 1893 to 1902, from London's "Story of a Typhoon" to The People of the Abyss. The Jack London who emerges in the pages of Author Under Sail is a writer whose partnership with publishers, most notably his productive alliance with George Brett of Macmillan, was one of the most formative in American literary history. London pioneered many author models during the heyday of realism and naturalism, blurring the boundaries of these popular genres by focusing on absorption and theatricality and the representation of the seen and unseen. London created an impassioned, sincere, and extremely personal realism unlike that of other American writers of the time. Author Under Sail is a literary tour de force that reveals the full range of London as writer, creative citizen, and entrepreneur at the same time it sheds light on the maverick side of machine-age literature.Description based on publisher supplied metadata and other sources.Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, YYYY. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries
- …
